Chief

Department of General

Abdominal Surgery & Liver Transplantation

Hospital Universitario Vall d’Hebron

​

Professor Gonzalo Sapisochin is Chief of the Department of General, Abdominal Surgery & Liver Transplantation at the Hospital Universitario Vall d’Hebron in Barcelona. He obtained his Doctor of Medicine (MD) from the University Complutense of Madrid in 2005 and completed his general surgery residency at Hospital Universitario Vall d’Hebron in Barcelona in 2011. He further completed his PhD at the Autonoma University of Barcelona under the supervision of Dr. Ramon Charco in 2010. He honed his expertise with a Fellowship in abdominal transplant surgery & HPB surgical oncology at the University of Toronto in 2016 and holds a Master's degree in clinical epidemiology under the supervision of Dr. David Urbach from the same institution, completed in 2019. He also completed the prestigious Surgical Leadership Program at Harvard Medical School from 2021 to 2023.

A renowned transplant and hepatobiliary surgeon, Professor Sapisochin brings over 14 years of extensive experience in abdominal organ transplantation, including liver, pancreas, kidney transplant, and living donor liver transplant. He also specializes in complex hepatobiliary surgical oncology. Prior to his current leadership role in Barcelona, he was a Staff Surgeon in the Liver Transplant and Hepatobiliary Surgery Department at Hospital Universitario Vall d’Hebron in Barcelona from 2011 to 2013. He was then Associate Professor in the Division of General Surgery at the University of Toronto and the University Health Network (Toronto General Hospital) in the Department of Surgery from 2016 to 2025. His clinical expertise encompasses liver, kidney, and pancreas transplantation, with a particular focus on living-donor liver transplantation and the surgical management of hepatobiliary malignancies.

Professor Sapisochin is also a leading clinical researcher in the field of transplant oncology. He leads a research laboratory which focuses on clinical research in the fields of Transplant Oncology, Hepatocellular Carcinoma, and Cholangiocarcinoma. His contributions include over 200 original articles and 40 review articles in high-impact journals, such as The Lancet, JAMA Surgery, and Journal of Hepatology, and he holds an H-index of 56. He has frequently been invited to lecture internationally and actively contributes to several committees and governing boards of major academic societies in transplantation and hepatobiliary surgery.